GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 47 filers reported holding GALECTIN THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 0.20 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $110,222 | -3.2% | 48,771 | +2.3% | 0.00% | 0.0% |
Q1 2024 | $113,895 | +60.9% | 47,655 | +11.7% | 0.00% | 0.0% |
Q4 2023 | $70,807 | -2.5% | 42,655 | +12.8% | 0.00% | 0.0% |
Q3 2023 | $72,624 | +53.6% | 37,825 | +15.2% | 0.00% | – |
Q2 2023 | $47,268 | -31.4% | 32,825 | 0.0% | 0.00% | -100.0% |
Q1 2023 | $68,933 | +85.9% | 32,825 | +0.0% | 0.00% | – |
Q4 2022 | $37,075 | -30.0% | 32,810 | 0.0% | 0.00% | -100.0% |
Q3 2022 | $53,000 | -10.2% | 32,810 | -27.6% | 0.00% | 0.0% |
Q2 2022 | $59,000 | -33.7% | 45,335 | -18.0% | 0.00% | 0.0% |
Q1 2022 | $89,000 | -21.9% | 55,310 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $114,000 | -48.6% | 55,310 | -3.5% | 0.00% | -66.7% |
Q3 2021 | $222,000 | +13.3% | 57,310 | -6.5% | 0.00% | +50.0% |
Q2 2021 | $196,000 | +38.0% | 61,310 | -6.1% | 0.00% | 0.0% |
Q1 2021 | $142,000 | -91.7% | 65,310 | -91.5% | 0.00% | -92.3% |
Q4 2020 | $1,719,000 | -24.6% | 767,321 | -10.1% | 0.03% | -35.0% |
Q3 2020 | $2,279,000 | -12.5% | 853,716 | +0.3% | 0.04% | -18.4% |
Q2 2020 | $2,604,000 | +58.5% | 851,101 | +1.5% | 0.05% | +53.1% |
Q1 2020 | $1,643,000 | -31.7% | 838,265 | -0.3% | 0.03% | -17.9% |
Q4 2019 | $2,405,000 | -20.1% | 840,948 | +2.5% | 0.04% | -27.8% |
Q3 2019 | $3,010,000 | -8.3% | 820,158 | +3.7% | 0.05% | -11.5% |
Q2 2019 | $3,282,000 | -14.9% | 790,874 | +4.8% | 0.06% | -7.6% |
Q1 2019 | $3,855,000 | +56.3% | 754,355 | +4.9% | 0.07% | +37.5% |
Q4 2018 | $2,466,000 | -40.5% | 718,923 | +4.3% | 0.05% | -35.1% |
Q3 2018 | $4,143,000 | -0.8% | 689,278 | +5.0% | 0.07% | -9.8% |
Q2 2018 | $4,175,000 | +20.5% | 656,527 | -10.2% | 0.08% | +13.9% |
Q1 2018 | $3,466,000 | +50.8% | 731,300 | +6.3% | 0.07% | +50.0% |
Q4 2017 | $2,298,000 | +55.5% | 688,153 | -0.4% | 0.05% | +65.5% |
Q3 2017 | $1,478,000 | -18.6% | 690,960 | -6.4% | 0.03% | -29.3% |
Q2 2017 | $1,816,000 | -1.4% | 738,500 | -7.8% | 0.04% | -8.9% |
Q1 2017 | $1,841,000 | +159.7% | 800,590 | +10.5% | 0.04% | +181.2% |
Q4 2016 | $709,000 | +4.1% | 724,423 | +20.2% | 0.02% | -5.9% |
Q3 2016 | $681,000 | -18.5% | 602,731 | +5.9% | 0.02% | -32.0% |
Q2 2016 | $836,000 | +39.1% | 569,349 | +35.3% | 0.02% | +31.6% |
Q1 2016 | $601,000 | -1.2% | 420,810 | +13.5% | 0.02% | -5.0% |
Q4 2015 | $608,000 | -16.9% | 370,901 | +18.5% | 0.02% | -23.1% |
Q3 2015 | $732,000 | +89.6% | 312,886 | +121.0% | 0.03% | +100.0% |
Q2 2015 | $386,000 | -11.7% | 141,581 | +8.5% | 0.01% | -7.1% |
Q1 2015 | $437,000 | +4.5% | 130,500 | +8.3% | 0.01% | 0.0% |
Q4 2014 | $418,000 | -30.4% | 120,500 | +0.8% | 0.01% | -30.0% |
Q3 2014 | $601,000 | -77.6% | 119,600 | -38.4% | 0.02% | -78.0% |
Q2 2014 | $2,681,000 | +16.3% | 194,158 | +28.9% | 0.09% | +11.0% |
Q1 2014 | $2,306,000 | +47.9% | 150,643 | -21.9% | 0.08% | +41.4% |
Q4 2013 | $1,559,000 | – | 192,950 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Benchmark Capital Advisors | 221,700 | $1,051,000 | 0.83% |
EAM Global Investors LLC | 227,063 | $1,076,000 | 0.56% |
EAM Investors, LLC | 319,187 | $1,513,000 | 0.25% |
COURAGE CAPITAL MANAGEMENT LLC | 30,000 | $142,000 | 0.11% |
Cutter & CO Brokerage, Inc. | 53,600 | $254,000 | 0.10% |
SABBY MANAGEMENT, LLC | 286,800 | $1,360,000 | 0.08% |
D.A. DAVIDSON & CO. | 731,300 | $3,466,000 | 0.07% |
Tibra Equities Europe Ltd | 63,414 | $301,000 | 0.05% |
Advisor Group, Inc. | 556,377 | $2,637,000 | 0.04% |
Laurel Wealth Advisors, Inc. | 21,400 | $101,000 | 0.03% |